Aside from the ones you mentioned, the other DIC/sepsis programs to watch are Artisan Pharma’s ART-123 (which has been extensively discussed on this board lately) and NVS’ Tifacogin (#msg-15157973).
I’ll let someone else comment on the gram-positive vs gram-negative question because that’s not my bailiwick. Regards, Dew
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”